NCT07149272

Brief Summary

The goal of this study aims to analyze lactate kinetics as an exercise response after conventional multimodal exercise and virtual reality exercise (VRE) in hospitalized geriatric. The main question it aims to answer are:

  1. 1.are there any difference in post exercise lactate at day 1 and 7 between the two groups?
  2. 2.does the lactate concentration reduces after low intensity resistance exercise in subject with high resting lactate?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 29, 2025

Completed
Last Updated

August 29, 2025

Status Verified

August 1, 2025

Enrollment Period

1.3 years

First QC Date

August 14, 2025

Last Update Submit

August 27, 2025

Conditions

Keywords

ExerciseGeriatricLactateVirtual Reality

Outcome Measures

Primary Outcomes (1)

  • Change in Post-Exercise Blood Lactate Concentration (mmol/L)

    The absolute change in capillary blood lactate concentration (mmol/L) from pre-exercise to immediately post-exercise. This change will be calculated at two time points: at baseline (Day 1) and one week post-intervention (Day 7). The difference between the Day 7 change and the Day 1 change will be the primary outcome. Measurements will be taken using the StatStrip® Lactate Meter

    The change from pre- to post-exercise is measured on Day 1 and again on Day 7. The outcome is the comparison of these changes between the two days

Secondary Outcomes (2)

  • Lactate Clearance Rate (% change per minute)

    Measured during the recovery phase on Day 1 and Day 7. The outcome is the comparison of the clearance rates between the two days

  • Qualitative Pattern of Fatigue via Lactate Kinetics

    Patterns are assessed by comparing the kinetic profiles from Day 1 to Day 7

Study Arms (2)

Control Group

NO INTERVENTION

Conventional multimodal exercise (standard care)

VRE Intervention Group

EXPERIMENTAL

Conventional exercise + Virtual Reality Exercise (VRAGMENT software on Oculus Quest 2)

Device: Virtual Reality Exercise (VRE) using VRAGMENT software

Interventions

Adjuvant Virtual Reality Exercise (VRE) delivered via Oculus Quest 2 headset with VRAGMENT software, a culturally adapted VR program simulating daily activities (e.g., grocery shopping, phone calls) to induce physical movement. Participants received VRE alongside conventional multimodal exercise (breathing, resistance, aerobic) during hospitalization. Sessions were tailored to individual clinical conditions and aimed to improve fatigue and mobility through gamified rehabilitation

Also known as: VRAGMENT
VRE Intervention Group

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient age 60-90 years old in acute geriatric ward
  • mobilization level 3 and 4
  • able to communicate and follow instructions

You may not qualify if:

  • VR Sickness
  • severe psychosocial problems
  • severe caregiver burden

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RSUPN Dr. Cipto Mangunkusumo

Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

Location

Related Publications (7)

  • Cortes-Perez I, Sanchez-Alcala M, Nieto-Escamez FA, Castellote-Caballero Y, Obrero-Gaitan E, Osuna-Perez MC. Virtual Reality-Based Therapy Improves Fatigue, Impact, and Quality of Life in Patients with Multiple Sclerosis. A Systematic Review with a Meta-Analysis. Sensors (Basel). 2021 Nov 6;21(21):7389. doi: 10.3390/s21217389.

    PMID: 34770694BACKGROUND
  • Vavricka J, Broz P, Follprecht D, Novak J, Krouzecky A. Modern Perspective of Lactate Metabolism. Physiol Res. 2024 Aug 31;73(4):499-514. doi: 10.33549/physiolres.935331.

    PMID: 39264074BACKGROUND
  • Goodwin ML, Harris JE, Hernandez A, Gladden LB. Blood lactate measurements and analysis during exercise: a guide for clinicians. J Diabetes Sci Technol. 2007 Jul;1(4):558-69. doi: 10.1177/193229680700100414.

    PMID: 19885119BACKGROUND
  • Cho H, Sohng KY. The effect of a virtual reality exercise program on physical fitness, body composition, and fatigue in hemodialysis patients. J Phys Ther Sci. 2014 Oct;26(10):1661-5. doi: 10.1589/jpts.26.1661. Epub 2014 Oct 28.

    PMID: 25364137BACKGROUND
  • Schneider SM, Hood LE. Virtual reality: a distraction intervention for chemotherapy. Oncol Nurs Forum. 2007 Jan;34(1):39-46. doi: 10.1188/07.ONF.39-46.

    PMID: 17562631BACKGROUND
  • Patino-Hernandez D, David-Pardo DG, Borda MG, Perez-Zepeda MU, Cano-Gutierrez C. Association of Fatigue With Sarcopenia and its Elements: A Secondary Analysis of SABE-Bogota. Gerontol Geriatr Med. 2017 Apr 10;3:2333721417703734. doi: 10.1177/2333721417703734. eCollection 2017 Jan-Dec.

    PMID: 28474000BACKGROUND
  • Ioannou A, Papastavrou E, Avraamides MN, Charalambous A. Virtual Reality and Symptoms Management of Anxiety, Depression, Fatigue, and Pain: A Systematic Review. SAGE Open Nurs. 2020 Aug 27;6:2377960820936163. doi: 10.1177/2377960820936163. eCollection 2020 Jan-Dec.

    PMID: 33415290BACKGROUND

MeSH Terms

Conditions

FatigueMotor Activity

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants were blinded to group allocation (control vs. VRE intervention) to minimize performance bias
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study utilized a two-arm, parallel-group, randomized controlled trial (RCT) design with single-blinding to evaluate the efficacy of Virtual Reality Exercise (VRE) as an adjuvant therapy for hospitalized geriatric patients. Sixty participants were randomly assigned to either a control group receiving conventional multimodal exercise or an intervention group receiving conventional exercise plus VRE using VRAGMENT software on Oculus Quest 2. Both groups underwent simultaneous interventions with outcomes measured at baseline and one week post-intervention, focusing on lactate kinetics as the primary outcome. The single-blind design ensured participants were unaware of their group allocation to minimize bias, while clinicians administering the interventions remained unblinded due to the nature of the VR therapy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. dr. Melinda Harini, Sp.K.F.R., Ger. (K)

Study Record Dates

First Submitted

August 14, 2025

First Posted

August 29, 2025

Study Start

February 16, 2024

Primary Completion

May 30, 2025

Study Completion

May 30, 2025

Last Updated

August 29, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

IPD will not be shared to protect participant confidentiality

Locations